Peptides represent a large class of cell signaling molecules, and they are mainly produced by the classical secretory pathway or during protein degradation. The peptide profile of Danio rerio (zebrafish) shows a lack of information when compared with other consolidated animal models. The aim of this work was to characterize the peptide profile of zebrafish brain by using triplex reductive methylation of amines labeling and liquid chromatography coupled to electron spray mass spectrometry. A total of 411 peptide fragments were detected and 125 peptide sequences could be solved. Further analysis suggested that most of the peptides were fragments of intracellular cytosolic and mitochondrial proteins, and that 60% of the precursor proteins were cleaved at either their N- or C-terminal. The most common residue in the P1 position was leucine whereas other common residues were lysine, alanine, arginine, and phenylalanine. Rare cleavage sites at P1 position were histidine, glutamic acid, and isoleucine. The peptide profile of zebrafish brain has similarities with results previously described in mice brain peptidome studies. Thus, this study represents an important basis for the molecular understanding of zebrafish and its use as a model for human diseases.
Get full access to this article
View all access options for this article.
References
1.
LiL, SweedlerJV. Peptides in the brain: mass spectrometry–based measurement approaches and challenges. Annu Rev Anal Chem, 2008; 1:451–483.
2.
JensenJ. Regulatory peptides and control of food intake in non-mammalian vertebrates. Comp Biochem Physiol A Mol Integr Physiol, 2001; 128:471–479.
3.
GundlachAL, BurazinTC, LarmJA. Distribution, regulation and role of hypothalamic galanin systems: renewed interest in a pleiotropic peptide family. Clin Exp Pharmacol Physiol, 2001; 28:100–105.
4.
KiefferBL, Gavériaux-RuffC. Exploring the opioid system by gene knockout. Prog Neurobiol, 2002; 66:285–306.
5.
StefanoGB, FricchioneG, GoumonY, EschT. Pain, immunity, opiate and opioid compounds and health. Med Sci Monit, 2005; 11:MS47–MS53.
6.
RotzingerS, LovejoyDA, TanLA. Behavioral effects of neuropeptides in rodent models of depression and anxiety. Peptides, 2010; 31:736–756.
7.
HökfeltT, BartfaiT, BloomF. Neuropeptides: opportunities for drug discovery. Lancet Neurol, 2003; 2:463–472.
8.
TinocoAD, SaghatelianA. Investigating endogenous peptides and peptidases using peptidomics. Biochemistry, 2011; 50:7447–7461.
9.
PanH, CheFY, PengB, SteinerDF, PintarJE, FrickerLD. The role of prohormone convertase-2 in hypothalamic neuropeptide processing: a quantitative neuropeptidomic study. J Neurochem, 2006; 98:1763–1777.
10.
SteinerDF. The proprotein convertases. Curr Opin Chem Biol, 1998; 2:31–39.
11.
BermanY, MzhaviaN, PolonskaiaA, FurutaM, SteinerDF, PintarJE, et al.Defective prodynorphin processing in mice lacking prohormone convertase PC2. J Neurochem, 2000; 75:1763–1770.
12.
MatsumotoH, NoguchiJ, HorikoshiY, KawamataY, KitadaC, HinumaS, et al.Stimulation of prolactin release by prolactin-releasing peptide in rats. Biochem Biophys Res Commun, 1999; 259:321–324.
13.
FrickerLD, LimJ, PanH, CheFY. Peptidomics: identification and quantification of endogenous peptides in neuroendocrine tissues. Mass Spectrom Rev, 2006; 25:327–344.
14.
CheF-Y. Quantitative neuropeptidomics of microwave-irradiated mouse brain and pituitary. Mol Cell Proteomics, 2005; 4:1391–1405.
15.
MoranoC, ZhangX, FrickerLD. Multiple isotopic labels for quantitative mass spectrometry. Anal Chem, 2008; 80:9298–9309.
16.
LyonsPJ, FrickerLD. Peptidomic approaches to study proteolytic activity. Curr Protoc Protein Sci, 2011;Chapter 18:Unit18.13.
17.
CastroLM, CavalcantiDM, AraujoCB, RioliV, IcimotoMY, GozzoFC, et al.Peptidomic analysis of the neurolysin-knockout mouse brain. J Proteomics, 2014; 111:238–248.
18.
FrickerL. D. Analysis of mouse brain peptides using mass spectrometry-based peptidomics: implications for novel functions ranging from non-classical neuropeptides to microproteins. Mol Biosyst, 2010; 6:1355–1365.
19.
GelmanJS, SironiJ, CastroLM, FerroES, FrickerLD. Peptidomic analysis of human cell lines. J Proteome Res, 2011; 10:1583–1592.
20.
DasguptaS, YangC, CastroLM, TashimaAK, FerroES, Moir RD et al. Analysis of the yeast peptidome and comparison with the human peptidome. PLoS One, 2016; 11:e0163312.
21.
FrickerLD, GelmanJS, CastroLM, GozzoFC, FerroES. Peptidomic analysis of HEK293T cells: effect of the proteasome inhibitor epoxomicin on intracellular peptides. J Proteome Res, 2012; 11:1981–1990.
22.
GelmanJS, SironiJ, BerezniukI, DasguptaS, CastroLM, GozzoFC, et al.Alterations of the intracellular peptidome in response to the proteasome inhibitor bortezomib. PLoS One, 2013; 8:e53263.
23.
CunhaFM, BertiDA, FerreiraZS, KlitzkeCF, MarkusRP, FerroES. Intracellular peptides as natural regulators of cell signaling. J Biol Chem, 2008; 283:24448–24459.
24.
BertiDA, RussoLC, CastroLM, CruzL, GozzoFC, HeimannJC, et al.Identification of intracellular peptides in rat adipose tissue: insights into insulin resistance. Proteomics, 2012; 12:2668–2681.
25.
RussoLC, AsegaAF, CastroLM, NegraesPD, CruzL, GozzoFC, et al.Natural intracellular peptides can modulate the interactions of mouse brain proteins and thimet oligopeptidase with 14-3-3ɛ and calmodulin. Proteomics, 2012; 12:2641–2655.
26.
MonteER, RossatoC, LlanosRP, RussoLC, de CastroLM, GozzoFC, et al.Interferon-gamma activity is potentiated by an intracellular peptide derived from the human 19S ATPase regulatory subunit 4 of the proteasome. J Proteomics, 2017; 151:74–82.
27.
de AraujoCB, RussoLC, CastroLM, FortiFL, do MonteER, RioliV, et al.A novel intracellular peptide derived from G1/S cyclin D2 induces cell death. J Biol Chem, 2014; 289:16711–16726.
28.
SakaiC, IjazS, HoffmanEJ. Zebrafish models of neurodevelopmental disorders: past, present, and future. Front Mol Neurosci, 2018; 11:294.
29.
HoweK, ClarkMD, TorrojaCF, TorranceJ, BerthelotC, MuffatoM, et al.The zebrafish reference genome sequence and its relationship to the human genome. Nature, 2013; 496:498–503.
30.
Van CampKA, BaggermanG, BlustR, HussonSJ. Peptidomics of the zebrafish Danio rerio: in search for neuropeptides. J Proteomics, 2017; 150:290–296.
31.
CheFY, ZhangX, BerezniukI, CallawayM, LimJ, FrickerLD. Optimization of neuropeptide extraction from the mouse hypothalamus. J Proteome Res, 2007; 6:4667–4676.
32.
UdenfriendS, SteinS, BöhlenP, DairmanW, LeimgruberW, WeigeleM. Fluorescamine: a reagent for assay of amino acids, peptides, proteins, and primary amines in the picomole range. Science (80-.), 1972; 178:871–872.
33.
BoersemaPJ, AyeTT, Van VeenTAB, HeckAJR, MohammedS. Triplex protein quantification based on stable isotope labeling by peptide dimethylation applied to cell and tissue lysates. Proteomics, 2008; 8:4624–4632.
34.
MaB, ZhangK, HendrieC, LiangC, LiM, Doherty-KirbyA, et al.PEAKS: powerful software for peptide de novo sequencing by tandem mass spectrometry. Rapid Commun Mass Spectrom, 2003; 17:2337–2342.
35.
ZhangJ, XinL, ShanB, ChenW, XieM, YuenD, et al.PEAKS DB: de novo sequencing assisted database search for sensitive and accurate peptide identification. Mol Cell Proteomics, 2012; 11:M111.010587.
36.
FesenkoIA, ArapidiGP, SkripnikovAY, AlexeevDG, KostryukovaES, ManolovAI, et al.Specific pools of endogenous peptides are present in gametophore, protonema, and protoplast cells of the moss Physcomitrella patens. BMC Plant Biol, 2015; 15:87.
37.
GelmanJS, SironiJ, CastroLM, FerroES, FrickerLD. Hemopressins and other hemoglobin-derived peptides in mouse brain: comparison between brain, blood, and heart peptidome and regulation in Cpe fat/fat mice. J Neurochem, 2010; 113:871–880.
38.
ChenR, MaM, HuiL, ZhangJ, LiL. Measurement of neuropeptides in crustacean hemolymph via MALDI mass spectrometry. J Am Soc Mass Spectrom, 2009; 20:708–718.
39.
SköldK, SvenssonM, NorrmanM, SjögrenB, SvenningssonP, AndrénPE. The significance of biochemical and molecular sample integrity in brain proteomics and peptidomics: stathmin 2-20 and peptides as sample quality indicators. Proteomics, 2007; 7:4445–4456.
40.
Schulz-KnappeP, ZuchtHD, HeineG, JürgensM, HessR, SchraderM. Peptidomics: the comprehensive analysis of peptides in complex biological mixtures. Comb Chem High Throughput Screen, 2001; 4:207–217.
41.
SköldK, SvenssonM, KaplanA, BjörkestenL, AströmJ, AndrenPE. A neuroproteomic approach to targeting neuropeptides in the brain. Proteomics, 2002; 2:447–454.
42.
RioliV, GozzoFC, HeimannAS, LinardiA, KriegerJE, ShidaCS, et al.Novel natural peptide substrates for endopeptidase 24.15, neurolysin, and angiotensin-converting enzyme. J Biol Chem, 2003; 278:8547–8555.
43.
HeimannAS, FavaratoMH, GozzoFC, RioliV, CarreñoFR, EberlinMN, et al.ACE gene titration in mice uncovers a new mechanism for ACE on the control of body weight. Physiol Genomics, 2005; 20:173–182.
44.
DasguptaS, FishmanMA, MahallatiH, CastroLM, TashimaAK, FerroES, et al.Reduced levels of proteasome products in a mouse striatal cell model of Huntington's disease. PLoS One, 2015; 10:e0145333.
45.
HeimannAS, GomesI, DaleCS, PaganoRL, GuptaA, de SouzaLL, et al.Hemopressin is an inverse agonist of CB1 cannabinoid receptors. Proc Natl Acad Sci U S A, 2007; 104:20588–20593.
46.
GomesI, DaleCS, CastenK, GeignerMA, GozzoFC, FerroES, et al.Hemoglobin-derived peptides as novel type of bioactive signaling molecules. AAPS J, 2010; 12:658–669.
47.
DaleCS, PaganoRL, RioliV, HyslopS, GiorgiR, FerroES. Antinociceptive action of hemopressin in experimental hyperalgesia. Peptides, 2005; 26:431–436.
48.
FerroES, HyslopS, CamargoACM. Intracellullar peptides as putative natural regulators of protein interactions. J Neurochem, 2004; 91:769–777.
49.
Café-MendesCC, FerroES, TorrãoAS, CrunfliF, RioliV, SchmittA, et al.Peptidomic analysis of the anterior temporal lobe and corpus callosum from schizophrenia patients. J Proteomics, 2017; 151:97–105.
50.
CostaE, GuidottiA. Diazepam binding inhibitor (DBI): a peptide with multiple biological actions. Life Sci, 1991; 49:325–344.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
